Chimeric antigen receptor (CAR) T cells are about as cutting-edge as cancer care gets today. Having demonstrated the ability to eradicate tumor cells in up to 90% of patients1 with certain blood cancers, these engineered immune cells became the first class of gene therapy to win FDA approval in 2017—with Novartis’ Kymriah getting the nod […]
The post Custom CAR T Cells Made to Order appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Custom CAR T Cells Made to Order